시장보고서
상품코드
2035929

아데노신 삼인산(ATP) 생물발광을 이용한 신속 무균 검사 시장 보고서(2026년)

Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,791,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,816,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 12,841,000
카드담기
※ 부가세 별도
한글목차
영문목차

아데노신 삼인산(ATP) 생물발광을 이용한 신속 무균 검사 시장 규모는 최근 급성장하고 있습니다. 이 시장은 2025년 9억 6,000만 달러에서 2026년에는 10억 8,000만 달러로, CAGR은 12.7%를 나타낼 전망입니다. 지난 수년간의 성장 요인으로는 제약업계의 신속한 무균 검사에 대한 수요 증가, 기존 배양 기반 방법의 한계, 오염 관리에 대한 규제 당국의 관심 증가, 생명공학 제조 시설의 확장, 병원의 감염 관리 프로그램 확대 등을 꼽을 수 있습니다.

아데노신 삼인산(ATP) 생물발광을 이용한 신속 무균 검사 시장 규모는 향후 몇 년간 급성장이 전망되고 있습니다. 2030년에는 17억 6,000만 달러에 이르고, CAGR은 12.9%를 나타낼 전망입니다. 예측 기간 동안 이러한 성장은 자동화된 신속 검사 플랫폼의 채택 확대, 첨단 미생물 검출 기술에 대한 투자 증가, 식음료 안전 검사에 대한 수요 증가, 클린룸 제조 환경의 확대, 품질 보증 및 컴플라이언스 표준에 대한 관심 증가에 기인하는 것으로 분석됩니다. 예측 기간의 주요 동향으로는 신속한 미생물 검출법 채택 확대, 실시간 무균성 평가에 대한 수요 증가, 루미노미터 기반 시스템 이용 확대, 자동 생물발광 분석기 보급 및 배양법 기반 시험법에서 전환이 진행될 것으로 예측됩니다.

제약 및 생명공학 분야의 확대는 향후 아데노신 삼인산(ATP) 생물발광을 이용한 신속 무균 검사 시장의 성장을 견인할 것으로 예측됩니다. 제약 및 생명공학 분야에는 질병 예방 또는 치료를 목적으로 하는 의약품, 백신 및 생물학적 제제의 연구개발, 생산 및 상업화에 종사하는 산업이 포함됩니다. 이 분야는 연구개발에 대한 투자 증가로 인해 성장하고 있으며, 이를 통해 기업들은 신약 발견, 치료법 개선, 그리고 증가하는 의료 수요를 충족시키기 위한 생산 능력 확대에 박차를 가하고 있습니다. 아데노신 삼인산(ATP) 생물발광을 이용한 신속 무균 검사는 제약 및 바이오 의약품의 미생물 오염을 신속하게 감지하여 의약품 및 바이오 의약품의 안전성과 품질을 보장하고, 엄격한 규제 기준을 준수하면서 생산 속도를 높여 제약 및 생명공학 부문을 지원하고 있습니다. 예를 들어, 룩셈부르크에 본사를 둔 정부 기관인 유로스타트(Eurostat)에 따르면, 2025년 4월 기준 2024년 EU의 의약품 및 제약 제품 수출액은 2023년 대비 13.5% 증가한 3,163억 8,000만 달러(3,134억 유로)에 달했습니다. 또한, 2025년 1월 영국에 본사를 둔 업계 단체인 바이오산업협회(BIA)에 따르면, 영국의 생명공학 부문은 2024년 35억 파운드(약 44억 달러)의 투자를 확보하여 전년 대비 94% 증가한 것으로 나타났다고 밝혔습니다. 따라서 제약 및 생명공학 분야의 확장은 아데노신 삼인산(ATP) 생물발광을 이용한 신속 무균 검사 시장의 성장을 주도하고 있습니다.

아데노신 삼인산(ATP) 생물발광을 이용한 신속 무균 검사 시장에서 사업을 전개하는 주요 기업들은 배치 릴리스 시간을 단축하고 품질 관리(QC)의 효율성을 향상시키기 위해 가속 무균 테스트와 같은 혁신적인 방법의 개발에 주력하고 있습니다. ATP 생물발광법과 같은 신속 검출법을 사용하여 미생물 오염을 식별하는 가속 무균 시험은 배치 방출 시간 단축, 격리 기간 단축 및 품질 관리의 전반적인 효율성 향상에 기여합니다. 예를 들어, 2026년 1월 네덜란드에 본사를 둔 바이오테크놀러지 기업 Biotactical B.V.는 ATP 생물 발광과 가속 배양 배지를 결합하여 단 48시간 만에 미생물 오염을 검출하는 혁신적인 솔루션인 가속형 신속 무균 테스트 플랫폼을 출시했습니다. 이 시스템은 GMP 준수 환경을 위해 설계되었으며, 첨단 치료용 의약품(ATMP)을 포함한 복잡하고 유통기한이 짧은 제품에 대응할 수 있습니다. 이 플랫폼은 의약품 품질 관리 워크플로우의 주요 병목현상을 해소하고, 로트 출시의 신속성과 재고 관리의 효율성을 높일 수 있습니다.

자주 묻는 질문

  • 아데노신 삼인산(ATP) 생물발광을 이용한 신속 무균 검사 시장 규모는 어떻게 변화하고 있나요?
  • 아데노신 삼인산(ATP) 생물발광을 이용한 신속 무균 검사 시장의 성장 요인은 무엇인가요?
  • 아데노신 삼인산(ATP) 생물발광을 이용한 신속 무균 검사 시장의 주요 동향은 무엇인가요?
  • 제약 및 생명공학 분야의 확대가 신속 무균 검사 시장에 미치는 영향은 무엇인가요?
  • 아데노신 삼인산(ATP) 생물발광을 이용한 신속 무균 검사 시장에서 주요 기업들은 어떤 혁신을 추구하고 있나요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 총 잠재 시장 규모

제9장 시장 세분화

제10장 지역 및 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남아메리카 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주목받는 스타트업

제40장 주요 인수합병(M&A)

제41장 시장 잠재력이 높은 국가, 부문, 전략

제42장 부록

KTH 26.05.18

Fast sterility testing using adenosine triphosphate (ATP) bioluminescence is a rapid technique for detecting microbial contamination by measuring ATP, an energy molecule present in all living cells. The enzyme luciferase reacts with ATP to produce light proportional to the number of viable microorganisms. The brightness of the emitted light provides near-instant sterility assessment compared to conventional culture-based methods.

The primary technologies of fast sterility testing by adenosine triphosphate bioluminescence include adenosine triphosphate bioluminescence, membrane filtration, and direct inoculation. Adenosine triphosphate (ATP) bioluminescence refers to a method using light emission from ATP-driven reactions to detect and quantify living cells or microbial contamination. Product types include instruments, reagents and kits, and consumables. Applications span pharmaceutical and biotechnology, food and beverage, medical devices, water and environmental, cosmetics and personal care, and others, serving hospitals and clinics, laboratories, research institutes, and other end-users.

Tariffs on imported laboratory instruments, luminometers, reagents, and specialized bioluminescence kits are impacting the fast sterility testing by ATP bioluminescence market by increasing procurement and manufacturing costs, particularly affecting instruments and reagents and kits segments. Regions such as North America and Europe that depend on globally sourced analytical components and consumables are most affected. Pharmaceutical and biotechnology applications face higher operational expenses due to reliance on precision equipment. However, tariffs are encouraging localized production of reagents and analytical systems, strengthening domestic supply chains and fostering innovation in cost-effective rapid sterility testing solutions.

The fast sterility testing by adenosine triphosphate (atp) bioluminescence market research report is one of a series of new reports from The Business Research Company that provides fast sterility testing by adenosine triphosphate (atp) bioluminescence market statistics, including fast sterility testing by adenosine triphosphate (atp) bioluminescence industry global market size, regional shares, competitors with a fast sterility testing by adenosine triphosphate (atp) bioluminescence market share, detailed fast sterility testing by adenosine triphosphate (atp) bioluminescence market segments, market trends and opportunities, and any further data you may need to thrive in the fast sterility testing by adenosine triphosphate (atp) bioluminescence industry. This fast sterility testing by adenosine triphosphate (atp) bioluminescence market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fast sterility testing by adenosine triphosphate (ATP) bioluminescence market size has grown rapidly in recent years. It will grow from $0.96 billion in 2025 to $1.08 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing need for faster sterility testing in pharmaceuticals, limitations of traditional culture-based methods, rising regulatory emphasis on contamination control, growth of biotechnology manufacturing facilities, expanding hospital infection control programs.

The fast sterility testing by adenosine triphosphate (ATP) bioluminescence market size is expected to see rapid growth in the next few years. It will grow to $1.76 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to growing adoption of automated rapid testing platforms, increasing investment in advanced microbial detection technologies, rising demand from food and beverage safety testing, expansion of cleanroom manufacturing environments, increasing focus on quality assurance and compliance standards. Major trends in the forecast period include increasing adoption of rapid microbial detection methods, rising demand for real-time sterility assessment, growing use of luminometer based systems, expansion of automated bioluminescence analyzers, increasing replacement of culture-based testing methods.

The expansion of the pharmaceutical and biotechnology sectors is expected to propel the growth of the fast sterility testing by adenosine triphosphate (ATP) bioluminescence market going forward. The pharmaceutical and biotechnology sectors encompass industries engaged in the research, development, production, and commercialization of drugs, vaccines, and biologically-based therapies to prevent or treat diseases. These sectors are growing due to increasing investment in research and development, which enables companies to discover new drugs, enhance therapies, and expand production capacity to meet rising healthcare demands. Fast sterility testing by adenosine triphosphate (ATP) bioluminescence supports the pharmaceutical and biotechnology sectors by rapidly detecting microbial contamination, ensuring the safety and quality of drugs and biologics, and enabling faster production while maintaining compliance with stringent regulatory standards. For instance, in April 2025, according to Eurostat, a Luxembourg-based government agency, EU exports of medicinal and pharmaceutical products in 2024 increased by 13.5% compared with 2023, reaching $316.38 billion (€313.4 billion). Additionally, in January 2025, according to the BioIndustry Association (BIA), a UK-based trade association, the UK biotech sector experienced significant growth in 2024, securing £3.5 billion (approximately $4.4 billion) in investment, representing a 94% increase from the previous year. Therefore, expansion in the pharmaceutical and biotechnology sectors is driving the growth of the fast sterility testing by adenosine triphosphate (ATP) bioluminescence market.

Leading companies operating in the fast sterility testing by adenosine triphosphate (ATP) bioluminescence market are focusing on developing innovative methods such as accelerated sterility tests to shorten batch release times and improve QC efficiency. Accelerated sterility tests, which use rapid detection methods such as ATP bioluminescence to identify microbial contamination, help shorten batch release times, reduce quarantine periods, and improve overall quality control efficiency. For example, in January 2026, Biotactical B.V., a Netherlands-based biotechnology company, launched its accelerated rapid sterility testing platform, an innovative solution that combines ATP bioluminescence with accelerated growth media to detect microbial contamination in just 48 hours. The system is designed for GMP-compliant environments and supports complex, short-shelf-life products, including advanced therapeutic medicinal products (ATMPs). The platform provides accelerated detection, reduces handling time, minimizes contamination risk, and aligns with USP <71>, <73>, <1223> and Ph. Eur. 2.6 and 5.1.6 standards, enabling faster batch release and more efficient inventory management while addressing a key bottleneck in pharmaceutical quality control workflows.

In September 2025, LuminUltra Technologies Ltd., a Canada-based healthcare technology company, acquired GL Biocontrol for an undisclosed amount. Through this acquisition, LuminUltra aims to strengthen its European presence, enhance its microbial water diagnostics capabilities, and accelerate the creation and deployment of innovative, rapid testing solutions that meet regulatory compliance and operational efficiency requirements for municipal and industrial water systems. GL Biocontrol SAS is a France-based technology company specializing in rapid microbiological testing using 2nd generation ATP bioluminescence technology.

Major companies operating in the fast sterility testing by adenosine triphosphate (atp) bioluminescence market are 3M Company, Merck KGaA, Lonza Group AG, SGS SA, Kikkoman Biochemifa, Charles River Laboratories, BioMerieux, Hach Company, Neogen Corporation, Charm Sciences, Promega Corporation, LuminUltra Technologies, Sopex d.o.o., Nelson Laboratories LLC, Hygiena LLC, PCE Instruments, Berthold Technologies, BioThema AB, Pharmetric Laboratory, Biotactical B.V., Promicol BV.

North America was the largest region in the fast sterility testing by adenosine triphosphate (ATP) bioluminescence market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast sterility testing by adenosine triphosphate (atp) bioluminescence market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fast sterility testing by adenosine triphosphate (atp) bioluminescence market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fast sterility testing by adenosine triphosphate (ATP) bioluminescence market consists of revenues earned by entities by providing services such as rapid sterility assessment of pharmaceutical and medical products, environmental monitoring in cleanrooms and manufacturing facilities, quality control testing for food and beverage industries, and validation or verification of sterilization processes. The market value includes the value of related goods sold by the service provider or included within the service offering. The fast sterility testing by adenosine triphosphate (ATP) bioluminescence market also includes sales of luminometers and handheld ATP meters, ATP reagents and substrates, swabs and sample collection devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses fast sterility testing by adenosine triphosphate (atp) bioluminescence market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fast sterility testing by adenosine triphosphate (atp) bioluminescence ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The fast sterility testing by adenosine triphosphate (atp) bioluminescence market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Technology: Adenosine Triphosphate Bioluminescence; Membrane Filtration; Direct Inoculation
  • 2) By Product Type: Instruments; Reagents And Kits; Consumables
  • 3) By Application: Pharmaceutical And Biotechnology; Food And Beverage; Medical Devices; Water And Environmental; Cosmetics And Personal Care; Other Applications
  • 4) By End-User: Hospitals And Clinics; Laboratories; Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Adenosine Triphosphate Bioluminescence: Luminometer Based Systems; Handheld Rapid Detection Kits; Automated Bioluminescence Analyzers
  • 2) By Membrane Filtration: Vacuum Filtration Units; Gravity Filtration Systems; Automated Membrane Filtration Instruments
  • 3) By Direct Inoculation: Broth Culture Methods; Agar Plate Culture Methods; Automated Inoculation Systems
  • Companies Mentioned: 3M Company; Merck KGaA; Lonza Group AG; SGS SA; Kikkoman Biochemifa; Charles River Laboratories; BioMerieux; Hach Company; Neogen Corporation; Charm Sciences; Promega Corporation; LuminUltra Technologies; Sopex d.o.o.; Nelson Laboratories LLC; Hygiena LLC; PCE Instruments; Berthold Technologies; BioThema AB; Pharmetric Laboratory; Biotactical B.V.; Promicol BV.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Rapid Microbial Detection Methods
    • 4.2.2 Rising Demand For Real-Time Sterility Assessment
    • 4.2.3 Growing Use Of Luminometer Based Systems
    • 4.2.4 Expansion Of Automated Bioluminescence Analyzers
    • 4.2.5 Increasing Replacement Of Culture-Based Testing Methods

5. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Laboratories
  • 5.3 Research Institutes
  • 5.4 Pharmaceutical And Biotechnology Companies
  • 5.5 Food And Beverage Manufacturers

6. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Segmentation

  • 9.1. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Adenosine Triphosphate Bioluminescence, Membrane Filtration, Direct Inoculation
  • 9.2. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Instruments, Reagents And Kits, Consumables
  • 9.3. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical And Biotechnology, Food And Beverage, Medical Devices, Water And Environmental, Cosmetics And Personal Care, Other Applications
  • 9.4. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Laboratories, Research Institutes, Other End-Users
  • 9.5. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Sub-Segmentation Of Adenosine Triphosphate Bioluminescence, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Luminometer Based Systems, Handheld Rapid Detection Kits, Automated Bioluminescence Analyzers
  • 9.6. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Sub-Segmentation Of Membrane Filtration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Vacuum Filtration Units, Gravity Filtration Systems, Automated Membrane Filtration Instruments
  • 9.7. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Sub-Segmentation Of Direct Inoculation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Broth Culture Methods, Agar Plate Culture Methods, Automated Inoculation Systems

10. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Regional And Country Analysis

  • 10.1. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 11.1. Asia-Pacific Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 12.1. China Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 13.1. India Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 14.1. Japan Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 15.1. Australia Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 16.1. Indonesia Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 17.1. South Korea Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 18.1. Taiwan Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 19.1. South East Asia Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 20.1. Western Europe Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 21.1. UK Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 22.1. Germany Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 23.1. France Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 24.1. Italy Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 25.1. Spain Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 26.1. Eastern Europe Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 27.1. Russia Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 28.1. North America Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 29.1. USA Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 30.1. Canada Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 31.1. South America Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 32.1. Brazil Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 33.1. Middle East Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

  • 34.1. Africa Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Regulatory and Investment Landscape

36. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Competitive Landscape And Company Profiles

  • 36.1. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Company Profiles
    • 36.3.1. 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. SGS SA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Kikkoman Biochemifa Overview, Products and Services, Strategy and Financial Analysis

37. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Other Major And Innovative Companies

  • Charles River Laboratories, BioMerieux, Hach Company, Neogen Corporation, Charm Sciences, Promega Corporation, LuminUltra Technologies, Sopex d.o.o., Nelson Laboratories LLC, Hygiena LLC, PCE Instruments, Berthold Technologies, BioThema AB, Pharmetric Laboratory, Biotactical B.V.

38. Global Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market

41. Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market High Potential Countries, Segments and Strategies

  • 41.1 Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Fast Sterility Testing By Adenosine Triphosphate (ATP) Bioluminescence Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기